Factor V Leiden (English Wikipedia)

Klarin D, Busenkell E, Judy R, Lynch J, Levin M, Haessler J, et al. (November 2019). "Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease" (PDF). Nature Genetics. 51 (11): 1574–1579. doi:10.1038/s41588-019-0519-3. PMC 6858581. PMID 31676865. Archived from the original (PDF) on 2020-01-28. Retrieved 2020-01-28.
Ridker PM, Miletich JP, Hennekens CH, Buring JE (1997). "Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening". JAMA. 277 (16): 1305–7. doi:10.1001/jama.277.16.1305. PMID 9109469.
Gregg JP, Yamane AJ, Grody WW (December 1997). "Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations". American Journal of Medical Genetics. 73 (3): 334–6. doi:10.1002/(SICI)1096-8628(19971219)73:3<334::AID-AJMG20>3.0.CO;2-J. PMID 9415695.
De Stefano V, Chiusolo P, Paciaroni K, Leone G (1998). "Epidemiology of factor V Leiden: clinical implications". Seminars in Thrombosis and Hemostasis. 24 (4): 367–79. doi:10.1055/s-2007-996025. PMID 9763354. S2CID 45534038.
Bertina RM, Koeleman BP, Koster T, et al. (May 1994). "Mutation in blood coagulation factor V associated with resistance to activated protein C". Nature. 369 (6475): 64–7. Bibcode:1994Natur.369...64B. doi:10.1038/369064a0. PMID 8164741. S2CID 4314040.
Kujovich JL (January 2011). "Factor V Leiden thrombophilia". Genetics in Medicine. 13 (1): 1–16. doi:10.1097/GIM.0b013e3181faa0f2. PMID 21116184.
Juul, Klaus; Tybjærg-Hansen, Anne; Steffensen, Rolf; Kofoed, Steen; Jensen, Gorm; Nordestgaard, Børge Grønne (2002-07-01). "Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses". Blood. 100 (1): 3–10. doi:10.1182/blood-2002-01-0111. ISSN 1528-0020. PMID 12070000. S2CID 9556602.
Ng, N; Brown, JRI; Edmondson, RA; Tillyer, Ml (May 2000). "LESSON OF THE MONTH – Catastrophic Arterial Thromboembolism Associated with Factor V Leiden". European Journal of Vascular and Endovascular Surgery. 19 (5): 551–553. doi:10.1053/ejvs.1999.0971. PMID 10828239.
Ornstein, Deborah L.; Cushman, Mary (2003). "Factor V Leiden". Circulation. 107 (15): e94-7. doi:10.1161/01.CIR.0000068167.08920.F1. ISSN 0009-7322. PMID 12707252.
Keo, Hong H; Fahrni, Jennifer; Husmann, Marc; Gretener, Silvia B. (2015). "Assessing the risk of recurrent venous thromboembolism – a practical approach". Vascular Health and Risk Management. 11: 451–9. doi:10.2147/VHRM.S83718. ISSN 1178-2048. PMC 4544622. PMID 26316770.
Nichols WL, Heit JA (September 1996). "Activated protein C resistance and thrombosis". Mayo Clin Proc. 71 (9): 897–8. doi:10.4065/71.9.897. PMID 8790269.
Rodger MA, Paidas M, McLintock C, et al. (August 2008). "Inherited thrombophilia and pregnancy complications revisited". Obstetrics and Gynecology. 112 (2 Pt 1): 320–24. doi:10.1097/AOG.0b013e31817e8acc. PMID 18669729.

fhcrc.org

kooperberg.fhcrc.org

Klarin D, Busenkell E, Judy R, Lynch J, Levin M, Haessler J, et al. (November 2019). "Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease" (PDF). Nature Genetics. 51 (11): 1574–1579. doi:10.1038/s41588-019-0519-3. PMC 6858581. PMID 31676865. Archived from the original (PDF) on 2020-01-28. Retrieved 2020-01-28.

genome.gov

What do we know about heredity and factor V Leiden thrombophilia? http://www.genome.gov/15015167#Q5

haematologica.org

De Stefano V, Leone G (1995). "Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia". Haematologica. 80 (4): 344–56. PMID 7590506.

harvard.edu

ui.adsabs.harvard.edu

Bertina RM, Koeleman BP, Koster T, et al. (May 1994). "Mutation in blood coagulation factor V associated with resistance to activated protein C". Nature. 369 (6475): 64–7. Bibcode:1994Natur.369...64B. doi:10.1038/369064a0. PMID 8164741. S2CID 4314040.

medlineplus.gov

"Factor V Leiden thrombophilia: MedlinePlus Genetics".

nih.gov

pubmed.ncbi.nlm.nih.gov

Klarin D, Busenkell E, Judy R, Lynch J, Levin M, Haessler J, et al. (November 2019). "Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease" (PDF). Nature Genetics. 51 (11): 1574–1579. doi:10.1038/s41588-019-0519-3. PMC 6858581. PMID 31676865. Archived from the original (PDF) on 2020-01-28. Retrieved 2020-01-28.
De Stefano V, Leone G (1995). "Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia". Haematologica. 80 (4): 344–56. PMID 7590506.
Ridker PM, Miletich JP, Hennekens CH, Buring JE (1997). "Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening". JAMA. 277 (16): 1305–7. doi:10.1001/jama.277.16.1305. PMID 9109469.
Gregg JP, Yamane AJ, Grody WW (December 1997). "Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations". American Journal of Medical Genetics. 73 (3): 334–6. doi:10.1002/(SICI)1096-8628(19971219)73:3<334::AID-AJMG20>3.0.CO;2-J. PMID 9415695.
De Stefano V, Chiusolo P, Paciaroni K, Leone G (1998). "Epidemiology of factor V Leiden: clinical implications". Seminars in Thrombosis and Hemostasis. 24 (4): 367–79. doi:10.1055/s-2007-996025. PMID 9763354. S2CID 45534038.
Bertina RM, Koeleman BP, Koster T, et al. (May 1994). "Mutation in blood coagulation factor V associated with resistance to activated protein C". Nature. 369 (6475): 64–7. Bibcode:1994Natur.369...64B. doi:10.1038/369064a0. PMID 8164741. S2CID 4314040.
Kujovich JL (January 2011). "Factor V Leiden thrombophilia". Genetics in Medicine. 13 (1): 1–16. doi:10.1097/GIM.0b013e3181faa0f2. PMID 21116184.
Juul, Klaus; Tybjærg-Hansen, Anne; Steffensen, Rolf; Kofoed, Steen; Jensen, Gorm; Nordestgaard, Børge Grønne (2002-07-01). "Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses". Blood. 100 (1): 3–10. doi:10.1182/blood-2002-01-0111. ISSN 1528-0020. PMID 12070000. S2CID 9556602.
Ng, N; Brown, JRI; Edmondson, RA; Tillyer, Ml (May 2000). "LESSON OF THE MONTH – Catastrophic Arterial Thromboembolism Associated with Factor V Leiden". European Journal of Vascular and Endovascular Surgery. 19 (5): 551–553. doi:10.1053/ejvs.1999.0971. PMID 10828239.
Ornstein, Deborah L.; Cushman, Mary (2003). "Factor V Leiden". Circulation. 107 (15): e94-7. doi:10.1161/01.CIR.0000068167.08920.F1. ISSN 0009-7322. PMID 12707252.
Keo, Hong H; Fahrni, Jennifer; Husmann, Marc; Gretener, Silvia B. (2015). "Assessing the risk of recurrent venous thromboembolism – a practical approach". Vascular Health and Risk Management. 11: 451–9. doi:10.2147/VHRM.S83718. ISSN 1178-2048. PMC 4544622. PMID 26316770.
Nichols WL, Heit JA (September 1996). "Activated protein C resistance and thrombosis". Mayo Clin Proc. 71 (9): 897–8. doi:10.4065/71.9.897. PMID 8790269.
Rodger MA, Paidas M, McLintock C, et al. (August 2008). "Inherited thrombophilia and pregnancy complications revisited". Obstetrics and Gynecology. 112 (2 Pt 1): 320–24. doi:10.1097/AOG.0b013e31817e8acc. PMID 18669729.

ncbi.nlm.nih.gov

Klarin D, Busenkell E, Judy R, Lynch J, Levin M, Haessler J, et al. (November 2019). "Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease" (PDF). Nature Genetics. 51 (11): 1574–1579. doi:10.1038/s41588-019-0519-3. PMC 6858581. PMID 31676865. Archived from the original (PDF) on 2020-01-28. Retrieved 2020-01-28.
"SNP linked to Gene F5". NCBI.
Keo, Hong H; Fahrni, Jennifer; Husmann, Marc; Gretener, Silvia B. (2015). "Assessing the risk of recurrent venous thromboembolism – a practical approach". Vascular Health and Risk Management. 11: 451–9. doi:10.2147/VHRM.S83718. ISSN 1178-2048. PMC 4544622. PMID 26316770.

pharmgkb.org

Jennifer Bushwitz; Michael A. Pacanowski & Julie A. Johnson (2006-10-11). "Important Variant Information for F5". PharmGKB. Archived from the original on 2011-07-27. Retrieved 2008-09-10.

semanticscholar.org

api.semanticscholar.org

De Stefano V, Chiusolo P, Paciaroni K, Leone G (1998). "Epidemiology of factor V Leiden: clinical implications". Seminars in Thrombosis and Hemostasis. 24 (4): 367–79. doi:10.1055/s-2007-996025. PMID 9763354. S2CID 45534038.
Bertina RM, Koeleman BP, Koster T, et al. (May 1994). "Mutation in blood coagulation factor V associated with resistance to activated protein C". Nature. 369 (6475): 64–7. Bibcode:1994Natur.369...64B. doi:10.1038/369064a0. PMID 8164741. S2CID 4314040.
Juul, Klaus; Tybjærg-Hansen, Anne; Steffensen, Rolf; Kofoed, Steen; Jensen, Gorm; Nordestgaard, Børge Grønne (2002-07-01). "Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses". Blood. 100 (1): 3–10. doi:10.1182/blood-2002-01-0111. ISSN 1528-0020. PMID 12070000. S2CID 9556602.

web.archive.org

Klarin D, Busenkell E, Judy R, Lynch J, Levin M, Haessler J, et al. (November 2019). "Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease" (PDF). Nature Genetics. 51 (11): 1574–1579. doi:10.1038/s41588-019-0519-3. PMC 6858581. PMID 31676865. Archived from the original (PDF) on 2020-01-28. Retrieved 2020-01-28.
Jennifer Bushwitz; Michael A. Pacanowski & Julie A. Johnson (2006-10-11). "Important Variant Information for F5". PharmGKB. Archived from the original on 2011-07-27. Retrieved 2008-09-10.

worldcat.org

search.worldcat.org

Juul, Klaus; Tybjærg-Hansen, Anne; Steffensen, Rolf; Kofoed, Steen; Jensen, Gorm; Nordestgaard, Børge Grønne (2002-07-01). "Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses". Blood. 100 (1): 3–10. doi:10.1182/blood-2002-01-0111. ISSN 1528-0020. PMID 12070000. S2CID 9556602.
Ornstein, Deborah L.; Cushman, Mary (2003). "Factor V Leiden". Circulation. 107 (15): e94-7. doi:10.1161/01.CIR.0000068167.08920.F1. ISSN 0009-7322. PMID 12707252.
Keo, Hong H; Fahrni, Jennifer; Husmann, Marc; Gretener, Silvia B. (2015). "Assessing the risk of recurrent venous thromboembolism – a practical approach". Vascular Health and Risk Management. 11: 451–9. doi:10.2147/VHRM.S83718. ISSN 1178-2048. PMC 4544622. PMID 26316770.

wsh.nhs.uk

"Factor V Leiden Mutation – Homozygous" (PDF).